Back
Universe Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
UPC
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
65
UPC
Universe Pharmaceuticals
Last Price:
2.19
Seasonality Move:
-30.81%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Universe Pharmaceuticals Price Quote
$2.19
-0.07 (-3.1%)
(Updated: May 2, 2024 at 6:55 PM ET)
Universe Pharmaceuticals Key Stats
Buy
65
Universe Pharmaceuticals (UPC)
is a Buy
Day range:
$2.26 - $2.57
52-week range:
$0.75 - $5.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.25
P/B ratio:
0.21%
Volume:
30.9K
Avg. volume:
101.5K
1-year change:
-37.22%
Market cap:
$8.2M
Revenue:
$32.3M
EPS:
$-1.7
How Much Does Universe Pharmaceuticals Make?
-
How Much Are Universe Pharmaceuticals's Sales Annually?
UPC Revenues are $32.3M -
How Much Profit Does Universe Pharmaceuticals's Make A Year?
UPC net income is -$6.2M
Is Universe Pharmaceuticals Growing As A Company?
Data Unavailable
Universe Pharmaceuticals Stock Price Performance
-
Did Universe Pharmaceuticals Stock Go Up Last Month?
Universe Pharmaceuticals share price went up by 3.2% last month -
Did UPC's Share Price Rise Over The Last Year?
UPC share price fell by -37.22% over the past 1 year
What Is Universe Pharmaceuticals 52-Week High & Low?
-
What Is Universe Pharmaceuticals’s 52-Week High Share Price?
Universe Pharmaceuticals has traded as high as $5.88 over the past 52 weeks -
What Is Universe Pharmaceuticals’s 52-Week Low Share Price?
Universe Pharmaceuticals has traded as low as $0.75 over the past 52 weeks
Universe Pharmaceuticals Price To Free Cash Flow
-
Is Universe Pharmaceuticals Stock Overvalued?
Universe Pharmaceuticals is trading at a price to free cash flow ratio of 7.61 -
Is Universe Pharmaceuticals Stock Undervalued?
Universe Pharmaceuticals EV to Free Cash Flow ratio is -4.44 -
What Is Universe Pharmaceuticals’s Price Earnings Growth Ratio?
UPC PEG ratio is 0.00 -
Is Universe Pharmaceuticals Trading At A Premium To Earnings?
Universe Pharmaceuticals EV to EBIT ratio is 0.00
Is It Risky To Buy Universe Pharmaceuticals?
-
How Much Debt Does Universe Pharmaceuticals Have?
Total long term debt quarterly is $5.5M -
How Much Cash Does Universe Pharmaceuticals Have?
Cash and short term investments quarterly total is $18.5M -
What Is Universe Pharmaceuticals’s Book Value Per Share?
Book value per share is 10.84
Is Universe Pharmaceuticals Cash Flow Positive?
-
What Is UPC Cash Flow From Operations?
Cash flow from operations (TTM) is $1.1M -
What Is Universe Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.4M -
What Is Universe Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$44.2K
Universe Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
UPC return on invested capital is -12.61% -
What Is Universe Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -10.09% -
What Is UPC Return On Equity?
ROE is a measure of profitability and is -13.89%
Universe Pharmaceuticals Earnings Date & Stock Price
-
What Is Universe Pharmaceuticals's Stock Price Today?
A single share of UPC can be purchased today for 2.26 -
What Is Universe Pharmaceuticals’s Stock Symbol?
Universe Pharmaceuticals trades on the nasdaq under the ticker symbol: UPC -
When Is Universe Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Universe Pharmaceuticals is scheduled on January 30, 2025 -
When Is UPC's next ex-dividend date?
Universe Pharmaceuticals's next ex-dividend date is May 3, 2024 -
How To Buy Universe Pharmaceuticals Stock?
You can buy Universe Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Universe Pharmaceuticals Competitors
-
Who Are Universe Pharmaceuticals's Competitors?
Below is a list of companies who compete with Universe Pharmaceuticals or are related in some way:
Universe Pharmaceuticals Dividend Yield
Data Unavailable
Universe Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |